Chan Henry Lee Sells 1,202 Shares of Beigene, Ltd. (NASDAQ:ONC) Stock

Beigene, Ltd. (NASDAQ:ONC) SVP Chan Henry Lee sold 1,202 shares of the stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $258.04, for a total value of $310,164.08. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Beigene Stock Up 0.5 %

Shares of ONC traded up $1.21 during mid-day trading on Tuesday, hitting $259.70. 619,630 shares of the stock were exchanged, compared to its average volume of 378,820. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.93 and a quick ratio of 1.72. The stock has a market capitalization of $25.41 billion, a price-to-earnings ratio of -31.52, a price-to-earnings-growth ratio of 7.73 and a beta of 0.63. Beigene, Ltd. has a 52-week low of $126.97 and a 52-week high of $265.89.

Beigene Company Profile

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.